Background: Several studies have shown the cost-effectiveness of direct oral anticoagulants
(DOACs), compared with warfarin, to prevent atrial fibrillation (AF) related complications …

Background: Women with atrial fibrillation are at a higher risk of stroke, despite treatment
with warfarin. It is unclear if women treated with direct oral anticoagulants (DOACs) have …

In the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation
study (NCT 02072434), edoxaban showed similar efficacy and safety versus enoxaparin …

Obesity is a significant cause of morbidity and mortality, and it is becoming increasingly
prevalent worldwide. Altered pharmacodynamics and pharmacokinetics of drugs in obese …

Background A considerable proportion of patients with atrial fibrillation (AF) are still treated
with aspirin despite current guidelines due to presumed favorable safety. Aim We performed …

Background and Purpose—Obesity has been associated with increased cardiovascular risk
in atrial fibrillation, but little is known in elderly patients with atrial fibrillation. Methods—Post …

Background: DOACs are characterized by a higher incidence of gastrointestinal bleeding
and this may be different among males and females. Female patients were …

Due to its constantly growing incidence, obesity is an increasingly serious social and
medical problem. Available data on the use of novel oral anticoagulants in morbidly obese …

Background: Elderly patients are at high risk of both ischaemic and bleeding events, and the
low body weight is considered a risk factor for major bleeding in atrial fibrillation (AF) …

Background: Direct oral anticoagulants (DOACs) have been widely used in patients with
atrial fibrillation (AF) for antithrombotic prophylaxis, which were shown to have a favorable …